申请人:Bristol-Myers Squibb Co.
公开号:US05990109A1
公开(公告)日:1999-11-23
Novel heterocyclo-substituted imidazopyrazines and salts thereof, pharmaceutical compositions containing such compounds, and methods of using such compounds in the treatment of protein tyrosine kinase-associated disorders such as immunologic disorders.
新型杂环取代咪唑吡嗪及其盐,含有这些化合物的制药组合物,并使用这些化合物治疗蛋白酪氨酸激酶相关疾病(如免疫性疾病)的方法。